Alberto Berral-Gonzalez

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer Drugs.

Alberto Berral-González, Monica M Arroyo, Diego Alonso-López

|Jan 25, 2025
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell Transcriptomics.

Enrique De La Rosa, Natalia Alonso-Moreda, Alberto Berral-González

|Feb 10, 2024
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours.

Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso

|Jul 14, 2023
Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer Cells.

Natalia Alonso-Moreda, Alberto Berral-González, Enrique De La Rosa

|Apr 25, 2023
Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms.

Santiago Bueno-Fortes, Alberto Berral-Gonzalez, José Manuel Sánchez-Santos

|Jan 11, 2022
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.

Santiago Bueno-Fortes, Julienne K Muenzner, Alberto Berral-Gonzalez

Pageof 1